Benjamin Sommer Hery Henry Peter Haider

15927006 (England and Wales)

52 Catherine Grove London London SE10 8FS England

Investments

4,209,771 

(4,209,671)

Called up share capital

100 

For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The financial statements were approved by the Board of Directors and authorised for issue on 23 December 2025 and were signed on its behalf by

Hery Henry Director Company Registration No. 15927006

Stronger Kaksi Ltd is a private company, limited by shares, registered in England and Wales, registration number 15927006. The registered office is 52 Catherine Grove, London, London, SE10 8FS, England.

The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.

A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price and are subsequently measured as follows: Debt instruments are subsequently measured at amortised cost and commitments to receive a loan and to make a loan to another entity are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. All other financial instruments, including derivatives, are initially recognised at fair value, which is normally the transaction price and are subsequently measured at fair value, with any changes recognised in profit or loss. Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

Short term debtors are measured at transaction price, less any impairment. Loans receivables are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

The Company has changed its financial year-end from 31 August 2025 to 31 March 2025 in order to align with the reporting dates of other companies within the group. As a result, the current reporting period represents seven months from 30 August 2024 to 31 March 2025.

Valuation at 30 August 2024

- 

Additions

4,209,771 

Valuation at 31 March 2025

Amounts owed to group undertakings and other participating interests

During the period the average number of employees was 0.